Triple-Negative Breast Cancer: 164 Real Stories

164 stories match breast cancer and triple-negative. 139 of them mention surgery.

Cancer Stories

Nahilys, who was diagnosed with Stage II Breast CancerBreast Cancer

Stage II Triple-Negative Breast Cancer: Nahilys's Patient Story

Patient Info: Nahilys | Stage II

Biomarkers: Triple-negative breast cancer.

Nahilys said she was well after treatment and continued surveillance every six months for triple-negative breast cancer.

Our Cancer Stories
OutcomeCare Ongoing
Anne, who was diagnosed with Stage III Breast CancerBreast Cancer

Stage III Triple-Negative Breast Cancer: Anne's Survivor Story

Patient Info: Anne, Female | Stage III

Biomarkers: ER-negative; PR-negative; HER2-negative

Anne completed chemotherapy during pregnancy, double mastectomy, radiotherapy, and additional chemotherapy for Stage III metaplastic triple-negative breast cancer and described using the experience as a source of personal transformation.

breastcancer.org
OutcomeSurvivorship / Completed Treatment
Toni, who was diagnosed with Breast CancerBreast Cancer

HR-Positive Breast Cancer: Toni's Patient Story

Patient Info: Toni S, Female, 50s

Biomarkers: ER-positive or PR-positive; HER2-positive; triple-positive breast cancer

Toni completed chemotherapy, surgery, Kadcyla, and radiation for triple-positive breast cancer with lymph-node involvement and continued anastrozole to suppress estrogen.

BreastCancer.org (ES)
OutcomeCare Ongoing
Stephanie, who was diagnosed with Stage II Invasive Ductal CarcinomaBreast Cancer

Stage II BRCA1 Invasive Ductal Carcinoma: Stephanie's Patient Story

Patient Info: Stephanie Hargis, Female, Under 40 | Stage II

Biomarkers: ER-negative; PR-negative; HER2-negative; BRCA1 mutation

Stephanie had Stage II triple-negative breast cancer with BRCA1 mutation, then a local recurrence in April 2023 without distant spread; after surgery, chemotherapy, Keytruda, radiation, and Lynparza, she remained in ongoing post-recurrence treatment.

BreastCancer.org (ES)
OutcomeCare Ongoing
Doris, who was diagnosed with Breast CancerBreast Cancer

Triple-Negative Breast Cancer: Doris's Survivor Story

Patient Info: Doris Teller, Female, 50s

Biomarkers: Triple-negative breast cancer

Doris completed 17 months of breast cancer treatment, returned to work for financial stability, recovered from lymphoedema, and continued to manage reconstruction asymmetry and memory changes after treatment.

Krankheitserfahrungen.de
OutcomeSurvivorship / Completed Treatment
Leanne, who was diagnosed with Stage IV Invasive Lobular CarcinomaBreast Cancer

Stage IV HR-Positive Invasive Lobular Carcinoma: Leanne's Patient Story

Patient Info: Leanne, Female, 50s | Stage IV

Biomarkers: ER-positive; PR-positive; HER2-positive

Metastatic Site: Brain

Leanne was first diagnosed in 2015 with Stage III triple-positive ILC and then diagnosed with metastatic lobular breast cancer with brain metastasis on April 4, 2018, causing major neurologic and work limitations.

Lobular Breast Cancer Alliance
OutcomeSetback / Progression
Valerie, who was diagnosed with Breast CancerBreast Cancer

Triple-Negative Breast Cancer: Valerie's Survivor Story

Patient Info: Valerie Hamilton, Female, 50s | Stage Metastatic/Advanced

Biomarkers: Triple-negative breast cancer; ER-negative; PR-negative; HER2-negative

Valerie completed chemotherapy, lumpectomy and radiation for locally advanced triple-negative breast cancer and preserved her breast/body image; no explicit NED or cancer-free status was provided.

Memorial Sloan Kettering
OutcomeSurvivorship / Surveillance
Cookie, who was diagnosed with Stage III Breast CancerBreast Cancer

Stage III Triple-Negative Breast Cancer: Cookie's Survivor Story

Patient Info: Cookie Joe, female | Stage III

Biomarkers: triple-negative

More than 5 years after her April 2021 diagnosis, she remains cancer-free (since December 2022) and continues breast-cancer advocacy, fundraising, and blood-donation efforts.

MD Anderson
OutcomeCancer-Free / NED
Melissa, who was diagnosed with Stage II Breast CancerBreast Cancer

Stage II Triple-Negative Breast Cancer: Melissa's Survivor Story

Patient Info: Melissa, Female | Stage II

Biomarkers: Triple-negative breast cancer; BRCA testing negative; NBN gene mutation identified on later testing

Melissa completed pregnancy-adapted cancer treatment, later underwent risk-reducing surgery and reconstruction, and was raising both daughters.

The Patient Story
OutcomeTreatment Completed / Survivorship
Alison, who was diagnosed with Stage IV Breast CancerBreast Cancer

Stage IV HR-Positive Breast Cancer: Alison's Survivor Story

Patient Info: Alison, Female, Under 40 | Stage IV

Biomarkers: ER-positive; PR-positive; HER2-positive

Metastatic Site: Cervical/neck lymph nodes

Alison reported complete remission since August 2017 while continuing intermittent maintenance chemotherapy, most recently 1 month of treatment followed by 2 months off.

The Patient Story
OutcomeLiving With Cancer / Remission
Stefanie, who was diagnosed with Stage III Invasive Ductal CarcinomaBreast Cancer

Stage III HR-Positive Invasive Ductal Carcinoma: Stefanie's Survivor Story

Patient Info: Stefanie, Female | Stage III

Biomarkers: ER-positive, PR-positive and HER2-positive

Stefanie completed chemotherapy, breast-conserving surgery, prolonged Herceptin and 30 radiation treatments, then moved into survivorship while still adjusting to the lasting effects of treatment.

The Patient Story
OutcomeTreatment Completed / Survivorship
Shari, who was diagnosed with Stage IV Invasive Ductal CarcinomaBreast Cancer

Stage IV HR-Positive Invasive Ductal Carcinoma: Shari's Patient Story

Patient Info: Shari S., Female | Stage IV

Biomarkers: ER-positive, PR-positive and HER2-positive; no inherited cancer mutation was identified

Metastatic Site: Brain; other initial metastatic sites were not named

Systemic imaging after chemotherapy showed no active disease, but brain metastases later required stereotactic radiation. Shari remained stage 4, continued Herceptin every 3 weeks and underwent brain MRI every 3–4 months.

The Patient Story
OutcomeLiving With Cancer / Ongoing Therapy
Lucy, who was diagnosed with Stage II Breast CancerBreast Cancer

Stage II Triple-Negative Breast Cancer: Lucy's Survivor Story

Patient Info: Lucy, Female, Under 40 | Stage II

Biomarkers: Germline BRCA1 mutation; triple-negative breast cancer

Surgical pathology was all clear on June 17 after a strong chemotherapy response. Lucy described herself as cancer-free and continued oncology reviews every 3–4 months while planning delayed reconstruction.

The Patient Story
OutcomeCancer-Free / NED, Surveillance
Wendi, who was diagnosed with Stage II Breast CancerBreast Cancer

Stage II Breast Cancer: Wendi's Survivor Story

Patient Info: Wendi Kushner | Stage II

Biomarkers: Triple-positive

After the clinical trial, lumpectomy pathology showed a complete pathological response with no residual cancer in the breast or lymph nodes.

MD Anderson
OutcomeCancer-Free / NED
A patient, who was diagnosed with Stage II Breast CancerBreast Cancer

Stage IIA triple-negative neuroendocrine breast carcinoma with chemoimmunotherapy response

Patient Info: Anonymized, Female, 70+ | Stage II

Biomarkers: Triple-negative neuroendocrine breast carcinoma with PD-L1 CPS >=10, and reported germline BRCA1/2 mutation.

As of March 2025, 12 months after surgery, follow-up imaging and tumor-marker testing showed no local recurrence or distant metastasis, and she remained in good general condition.

PubMed Central
OutcomeCancer-Free / NED
Kim, who was diagnosed with Breast CancerBreast Cancer

Triple-Negative Breast Cancer: Kim's Survivor Story

Patient Info: Kim Rumpf, Female

Biomarkers: ER-negative; PR-negative; HER2-negative

As of June 2026, Kim Rumpf was a triple-negative breast cancer survivor sharing her experience with chemotherapy, double mastectomy, reconstruction, fertility challenges, and advocacy.

Power Over Pink
OutcomeCancer-Free / NED
Janice, who was diagnosed with Stage IV Breast CancerBreast Cancer

Stage IV Triple-Negative Breast Cancer: Janice's Patient Story

Patient Info: Janice, Female, Under 40 | Stage IV

Biomarkers: ER-negative; PR-negative; HER2-negative

Metastatic Site: Other sites not specified

Living with incurable Stage IV triple-negative breast cancer while advocating for dose adjustments, symptom management, and balancing quality of life with survival.

The Patient Story
OutcomeLiving With Cancer
Erin, who was diagnosed with Stage IV Breast CancerBreast Cancer

Stage IV Triple-Negative Breast Cancer: Erin's Patient Story

Patient Info: Erin, Female | Stage IV

Biomarkers: ER-negative; PR-negative; HER2-negative; later tumor responded to androgen signaling

Metastatic Site: Lung; brain

As of June 2026, Erin was living with metastatic triple-negative breast cancer involving lung and brain, with tumors shrinking on ongoing Gemzar plus carboplatin chemotherapy every 2 weeks.

The Patient Story
OutcomeResponding Well
Stephanie, who was diagnosed with Stage III Breast CancerBreast Cancer

Stage III Triple-Negative Breast Cancer: Stephanie's Survivor Story

Patient Info: Stephanie, Female | Stage III

Biomarkers: ER-negative; PR-negative; HER2-negative; BRCA1 mutation

As of June 2026, Stephanie described being a 10-year survivor after Stage III BRCA1-positive triple-negative breast cancer, with remission shown after chemotherapy and no recurrence described.

The Patient Story
OutcomeCancer-Free / NED
Doreen, who was diagnosed with Stage II Invasive Ductal CarcinomaBreast Cancer

Stage II HR-Positive Invasive Ductal Carcinoma: Doreen's Patient Story

Patient Info: Doreen, Female | Stage II

Biomarkers: ER-positive; PR-positive; HER2-positive

As of June 2026, Doreen had completed TCHP chemotherapy with a complete response before surgery and had undergone lumpectomy and radiation for Stage IIA triple-positive breast cancer.

The Patient Story
OutcomeResponding Well
Rach, who was diagnosed with Stage II Breast CancerBreast Cancer

Stage II HR-Positive Breast Cancer: Rach's Patient Story

Patient Info: Rach D., Female, Under 40 | Stage II

Biomarkers: ER-positive; PR-positive; HER2-positive

As of June 2026, Rach described Stage II triple-positive breast cancer treated with fertility preservation, 6 rounds of neoadjuvant TCHP including Herceptin, Zoladex ovarian suppression, and double mastectomy with reconstruction.

The Patient Story
OutcomeCare Ongoing
A patient, who was diagnosed with Stage IV Invasive Ductal CarcinomaBreast Cancer

Metastatic triple-negative breast cancer with orbital and bone metastases responding to nab-paclitaxel plus everolimus

Patient Info: Anonymized, Female, 70+ | Stage IV

Biomarkers: Primary breast cancer was ER-low, PR/HER2 negative. Orbital metastasis was triple-negative with AKT1 exon 4 mutation.

Metastatic Site: right orbit/orbital mass; bone

At 6-month follow-up, systemic disease was stable, ocular symptoms had significantly improved, orbital metastases were stable on MRI, and the response was described as RECIST partial response/progression-free interval while treatment continued.

PubMed Central
OutcomeResponding Well